Literature DB >> 18521296

Chondrosarcoma of the pelvis: oncologic and functional outcome.

R J Wirbel1, M Schulte, B Maier, M Koschnik, W E Mutschler.   

Abstract

Purpose. Chondrosarcoma (CS) most commonly involves the pelvis. The factors that influence local and systemic control of pelvic CS and the functional outcome should be evaluated.Patients. Fifty-one patients (37 males and 14 females; mean age, 39.4 years) with pelvic CS were included in this retrospective study.Methods. The tumor stage, surgical treatment, surgical margin achieved, complications, incidence of local recurrence (LR), incidence of distant metastases, and the oncologic and functional status were evaluated. Oncologic outcome was estimated by the method of Kaplan and Meier, and the functional status was scored according to Musculoskeleral Tumor Society (MSTS) criteria. Analysis of variance was used to determine the factors that influence the oncologic and functional outcome.Results. Surgical stages were IA in three cases, IB in 23, IIB in 23, and III in two. Hemipelvectomy (H) was performed in 13 cases, internal hemipelvectomy (IH) with endoprosthetic replacement in 17, and continuity resection (CR) in 23.Two patients received IH and CR, one due to LR, and one due to instability. Radical or wide margins were achieved in 27 cases, marginal margins in 16, and intralesional margins in eight. Local complication required additional surgery in 10 cases due to local infections and/or hematomas.Two patients died perioperatively. In 48 out of the 49 remaining patients, follow-up was available with a mean duration of 73.4 months (range, 4-229 months).Twenty patients died of the disease, two patients are alive with metastases, four patients are disease free after LR, and 22 patients show no evidence of the disease. LR occurred in 10 cases (20.4%), and 17 patients (34.6%) developed distant metastases. Functional evaluation of the 28 survivors revealed good and excellent results in 19 cases, fair in three and poor in six.The mean MSTS score of all survivors was 69.2%, after H it was 37.6%, after IH was 61.4%, and after CR was 79.5%.Conclusion. In pelvic chondrosarcoma, survival was determined by the tumor stage and the surgical margin achieved.The incidence of LR was influenced by the surgical margin achieved, whereas the incidence of distant metastases was influenced by the tumor stage. The best oncologic results in chondrosarcoma involving the innominate bone could be found in low-grade tumors, and the best functional results after continuity resection and restoration of the pelvic girdle.

Entities:  

Year:  2000        PMID: 18521296      PMCID: PMC2395445          DOI: 10.1080/13577140020025878

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  17 in total

1.  Chondrosarcoma of the pelvis.

Authors:  T Ozaki; A Hillmann; N Lindner; S Blasius; W Winkelmann
Journal:  Clin Orthop Relat Res       Date:  1997-04       Impact factor: 4.176

2.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

3.  Prognostic factors for patients with sarcomas of the pelvic bones.

Authors:  A Kawai; J H Healey; P J Boland; P P Lin; A G Huvos; P A Meyers
Journal:  Cancer       Date:  1998-03-01       Impact factor: 6.860

4.  Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases.

Authors:  R C Marcove; V Miké; R V Hutter; A G Huvos; H Shoji; T R Miller; R Kosloff
Journal:  J Bone Joint Surg Am       Date:  1972-04       Impact factor: 5.284

5.  A system for the surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

6.  Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features.

Authors:  A Kreicbergs; L Boquist; B Borssén; S E Larsson
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

7.  Chondrosarcoma: a clinicopathologic and statistical analysis.

Authors:  D J Pritchard; R J Lunke; W F Taylor; D C Dahlin; B E Medley
Journal:  Cancer       Date:  1980-01-01       Impact factor: 6.860

8.  Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli.

Authors:  S Gitelis; F Bertoni; P Picci; M Campanacci
Journal:  J Bone Joint Surg Am       Date:  1981-10       Impact factor: 5.284

9.  Chondrosarcoma.

Authors:  J H Healey; J M Lane
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

10.  Resection and reconstruction for primary neoplasms involving the innominate bone.

Authors:  W F Enneking; W K Dunham
Journal:  J Bone Joint Surg Am       Date:  1978-09       Impact factor: 5.284

View more
  19 in total

1.  Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled Study.

Authors:  Sarah E Bosma; Arjen H G Cleven; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

2.  Acetabular Reconstruction With Femoral Head Autograft After Intraarticular Resection of Periacetabular Tumors is Durable at Short-term Followup.

Authors:  Xiaodong Tang; Wei Guo; Rongli Yang; Taiqiang Yan; Shun Tang; Dasen Li
Journal:  Clin Orthop Relat Res       Date:  2017-09-25       Impact factor: 4.176

3.  Internal hemipelvectomy is a safe procedure and provides a satisfying outcome for pelvic chondrosarcoma with coexisting pregnancy.

Authors:  I Gede Eka Wiratnaya
Journal:  J Clin Orthop Trauma       Date:  2019-06-01

Review 4.  Is it ever safe to discharge a chondrosarcoma of pelvis? Report of a local recurrence after 10 years.

Authors:  Czar Louie L Gaston; Vaiyapuri P Sumathi; Robert J Grimer
Journal:  Musculoskelet Surg       Date:  2012-09-19

Review 5.  [Hemipelvectomy for pelvic sarcomas].

Authors:  W K Guder; J Hardes; M Nottrott; A Streitbürger
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

6.  Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Authors:  Hidetatsu Outani; Kenichiro Hamada; Yoshinori Imura; Kazuya Oshima; Tsukasa Sotobori; Yusuke Demizu; Shigeki Kakunaga; Susumu Joyama; Reiko Imai; Tomoaki Okimoto; Norifumi Naka; Ikuo Kudawara; Takafumi Ueda; Nobuhito Araki; Tadashi Kamada; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

7.  Reconstruction After Hemipelvectomy With the Ice-Cream Cone Prosthesis: What Are the Short-term Clinical Results?

Authors:  Irene Barrientos-Ruiz; Eduardo José Ortiz-Cruz; Manuel Peleteiro-Pensado
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

8.  Surgical treatment of a twice recurrent chondrosarcoma of the pubic symphysis: a case report and review of the literature.

Authors:  George Petsatodis; Stavros I Stavridis; Dimitrios Karataglis; Anastasios Christodoulou
Journal:  Cases J       Date:  2009-06-29

9.  The Friedman-Eilber resection arthroplasty of the pelvis.

Authors:  Adam J Schwartz; Piya Kiatisevi; Fritz C Eilber; Frederick R Eilber; Jeffrey J Eckardt
Journal:  Clin Orthop Relat Res       Date:  2009-04-22       Impact factor: 4.176

Review 10.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.